728 x 90



  • Merck KGaA Expects 2023 Profit to Slip As COVID Demand Wanes

    Merck KGaA Expects 2023 Profit to Slip As COVID Demand Wanes0

    Germany’s Merck KGaA on Thursday predicted 2023 earnings would slip due to a decline at its electronic chemicals unit and a drop in COVID-related demand for its lab supplies from drug and vaccine makers. For 2023 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-offs, the company “assumes a moderate decline to an

    READ MORE